Literature DB >> 3108946

Recency of Pap smear screening: a multivariate model.

H L Howe, H Bzduch.   

Abstract

Most descriptive reports of women who have not received recent Pap smear screening have been limited to bivariate descriptions. The purpose of this study was to develop a multivariate model to predict the recency of Pap smear screening. A systematic sample of women residents, aged 25 to 74 years, in upstate New York was selected. The women were asked to report use of Pap smear screening during several time periods, their congruence with recommended medical practice, general use of medical services, and a variety of sociodemographic indicators. A log linear weighted least squares regression model was developed, and it explained 30 percent of the variance in recency of Pap smear screening behavior. While the sociodemographic variables were important predictors in the model, the medical care variables were the strongest predictors of recent Pap smear use. A significant relationship between race and recency of Pap smear testing was not supported by these data.

Entities:  

Mesh:

Year:  1987        PMID: 3108946      PMCID: PMC1477845     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  23 in total

1.  CYTOLOGICAL SCREENING FOR CANCER IN A VENEREAL DISEASE PROGRAM.

Authors:  A H PEDERSEN
Journal:  Public Health Rep       Date:  1964-12       Impact factor: 2.792

2.  DETECTION OF CANCER OF THE CERVIX: A PUBLIC HEALTH APPROACH.

Authors:  V H HANDY; E WIEBEN
Journal:  Obstet Gynecol       Date:  1965-03       Impact factor: 7.661

3.  The socioeconomic distribution of cancer of various sites in Buffalo, N.Y., 1948-1952.

Authors:  S GRAHAM; M LEVIN; A M LILIENFELD
Journal:  Cancer       Date:  1960 Jan-Feb       Impact factor: 6.860

4.  A survey of Pap smear screening in upstate New York.

Authors:  H L Howe; H Bzduch
Journal:  N Y State J Med       Date:  1986-06

5.  Epidemiologic evidence for the spectrum of change from dysplasia through carcinoma in situ to invasive cancer.

Authors:  L D Johnson; R J Nickerson; C L Easterday; R S Stuart; A T Hertig
Journal:  Cancer       Date:  1968-11       Impact factor: 6.860

6.  Control of cervix cancer in women of low income in a community.

Authors:  W M Christopherson; J E Parker
Journal:  Cancer       Date:  1969-07       Impact factor: 6.860

7.  Primary care of elderly women: is Pap smear screening necessary?

Authors:  J S Mandelblatt; D B Hammond
Journal:  Mt Sinai J Med       Date:  1985-04

8.  Descriptive epidemiology of cancer of the uterine cervix.

Authors:  S S Devesa
Journal:  Obstet Gynecol       Date:  1984-05       Impact factor: 7.661

9.  Cervical cancer control: a study of morbidity and mortality trends over a twenty-one-year period.

Authors:  W M Christopherson; F E Lundin; W M Mendez; J E Parker
Journal:  Cancer       Date:  1976-09       Impact factor: 6.860

10.  Efficacy of screening for cervical cancer: a review.

Authors:  D S Guzick
Journal:  Am J Public Health       Date:  1978-02       Impact factor: 9.308

View more
  4 in total

1.  The accuracy of Pap smear utilization self-report: a methodological consideration in cervical screening research.

Authors:  J A Bowman; S Redman; J A Dickinson; R Gibberd; R W Sanson-Fisher
Journal:  Health Serv Res       Date:  1991-04       Impact factor: 3.402

2.  Demographic predictors of mammography and Pap smear screening in US women.

Authors:  E E Calle; W D Flanders; M J Thun; L M Martin
Journal:  Am J Public Health       Date:  1993-01       Impact factor: 9.308

3.  Cancer control planning and establishment of priorities for intervention by a state health department.

Authors:  P P Lillquist; M H Alciati; M S Baptiste; P C Nasca; J F Kerner; C Mettlin
Journal:  Public Health Rep       Date:  1994 Nov-Dec       Impact factor: 2.792

4.  Cancer prevention behaviors among African-American adults: a survey of wards 7 and 8 in Washington, DC.

Authors:  S Shankar; V Y Kofie; K Helzlsouer; M L Rivo; G Bonney
Journal:  J Natl Med Assoc       Date:  1995-01       Impact factor: 1.798

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.